Patents Assigned to Molecular Technologies, Inc.
-
Patent number: 11666907Abstract: This document provides methods, devices, and systems for detecting the presence, absence, or amount of one or more analytes. For example, this document provides methods for using graphene-based sensors to detect one or more analytes (e.g., proteins, nucleic acids, intact cells, intact viruses, intact microorganisms, and/or chemicals).Type: GrantFiled: September 28, 2018Date of Patent: June 6, 2023Assignee: GRIP Molecular Technologies, Inc.Inventors: John Lalonde, Bruce Edgar Batten
-
Patent number: 11639356Abstract: Provided are compounds of formula (I): or cosmeceutically acceptable or pharmaceutically acceptable salts thereof. Additionally provided are cosmeceutical and/or pharmaceutical compositions comprising the compounds of formula (I), or the cosmeceutically acceptable or pharmaceutically acceptable salts thereof. Also provided are therapeutic and/or cosmetic methods using the cosmeceutical and/or pharmaceutical compositions comprising the compounds of formula (I), or the cosmeceutically acceptable or pharmaceutically acceptable salts thereof, for modulating cyclic adenosine monophosphate response element binding (CREB)-binding protein (CBP)/?-catenin mediated signaling in treating skin related diseases, conditions, or disorders mediated by aberrant CBP/?-catenin signaling and cosmetic methods for treating skin conditions mediated by aberrant CBP/?-catenin signaling.Type: GrantFiled: October 1, 2021Date of Patent: May 2, 2023Assignee: Genesis Molecular Technologies, Inc.Inventor: Fuqiang Ruan
-
Patent number: 7800070Abstract: A camera sub-module is provided for providing tomographic imaging of radiation emissions generated internally by a body. The camera sub-module includes a radiation-emitting layer having a radioactive source for emitting transmission emissions, and at least one radiation-detection layer for contemporaneously detecting and permitting differentiation between the transmission emissions and emissions generated internal to an imaged body administered with a positron-emitting radiotracer. Also provided herein are imaging systems, scanners, and other apparatus and methods.Type: GrantFiled: April 10, 2007Date of Patent: September 21, 2010Assignee: Quantum Molecular Technologies, Inc.Inventors: Irving Weinberg, Valeri Saveliev
-
Patent number: 7132540Abstract: The present invention discloses a series of novel hindered spiro-ketal nitroxides prepared by the ketalization reaction of 1,3-propanediols with triacetoneamine followed by oxidation. These novel spiro-ketals have unexpected advantages in hydrocarbon and monomer solubility which is important in styrene processing and refinery stream inhibition. Further, the invention shows an unexpected advantage over commercially available nitroxides in hydrocarbon solubility, especially in styrene and hydrocarbons. This invention also shows that these novel spiro-nitroxides are capable of inhibiting vinyl and acrylate polymerizations using an effective inhibition concentration of the nitroxide of the present invention.Type: GrantFiled: September 27, 2004Date of Patent: November 7, 2006Assignee: Nova Molecular Technologies Inc.Inventors: Mikolaj Jawdosiuk, George Sosnovsky, Jon Michael Clumpner, Anthony J. O'Lenick, Jr.
-
Patent number: 7045281Abstract: Division arrested cells are used in screening assays to determine the effect of a substance of interest on the cells. The division arrested cells can be used in drug screening assays, signal transduction assays, and are especially useful in large scale, high throughput assays.Type: GrantFiled: September 20, 2002Date of Patent: May 16, 2006Assignee: Cell & Molecular Technologies, Inc.Inventors: Thomas Livelli, Zhong Zhong, Mark Federici, Mei Cong
-
Patent number: 7022872Abstract: The invention relates to a method for preparing F-Dopa and 18F-Dopa and intermediates that are useful in the method. The invention is a method that synthesizes F-Dopa and 18F-Dopa in good yield with high enantiopurity without the need for further transformations. The method includes the step of reacting a benzaldehyde derivative with a phosphonic acid derivative to produces an olefin intermediate that can be asymmetrically hydrogenated to produce the desired enantiomer.Type: GrantFiled: December 19, 2003Date of Patent: April 4, 2006Assignee: Molecular Technologies, Inc.Inventors: Joseph C. Walsh, Henry C. Padgett
-
Publication number: 20040262158Abstract: A beta detector assembly for use in the synthesis and analysis of radiopharmaceuticals, such as in microfluidic radiochromatography. The beta detector assembly includes a base, preferably fabricated from glass so as to take advantage of electroosmotic flow, that serves as the body of the beta detector assembly. A microfluidic channel passes through the length of the base. A solid-state charge particle detector, for detecting beta particles, is provided and is positioned with respect to the base so as to receive beta particles. A portion of the base is disposed between the microfluidic channel and the solid-state charge particle detector and has a thickness that is selected to substantially allow transmission of beta particles there thru for detection by the charge particle detector. In one embodiment, the base is fabricated of glass. In another embodiment, the base is fabricated of silicon such that the base and the solid-state charge particle detector are integral.Type: ApplicationFiled: April 21, 2004Publication date: December 30, 2004Applicant: Molecular Technologies, Inc.Inventors: Charles W. Alvord, Charles Russell Buchanan, Joseph C. Matteo, Henry Clifton Padgett, Thomas Lee Collier
-
Publication number: 20040258615Abstract: The invention provides a method and apparatus for preparation of radiochemicals wherein the reaction that couples the radioactive isotope to the reactive precursor to form a positron-emitting molecular imaging probe is performed in a microfluidic environment.Type: ApplicationFiled: April 20, 2004Publication date: December 23, 2004Applicant: Molecular Technologies, Inc.Inventors: Charles Russell Buchanan, Henry C. Padgett, Thomas Lee Collier, Joseph C. Matteo, Charles W. Alvord
-
Patent number: 6458999Abstract: The present invention is related to a series of derivatives of novel ether diamine compounds prepared by the cyanobutylation reaction of an alcohol having 3 to 22 carbon atoms with 2-pentenenitrile to form a branched alkyl ether nitrile. The etheraminonitriles formed by the process are hydrogenated to form alkylether amines. The resulting product can be reacted with 2-pentenenitrile and or acrylonitrile and in a subsequent step, hydrogenated to yield a diamine. Specifically, the present invention deals with two types of tertiary amines one made by the reaction of novel ether diamines compounds with ethylene oxide, propylene oxide or butylene oxide or mixtures thereof, producing alkoxylated tertiary amines and the other made by the reaction of novel ether amine compounds with formaldehyde and hydrogen producing methylated tertiary amines. The invention also disclosed novel amine oxides, and quaternary compounds made from said tertiary amines.Type: GrantFiled: November 27, 2000Date of Patent: October 1, 2002Assignee: Nova Molecular Technologies INCInventors: Thomas J. Daly, Michael Clumpner, Anthony J. O'Lenick, Jr.
-
Patent number: 6426436Abstract: The present invention is related to a series of derivatives of novel ether diamine compounds prepared by the cynobutylation reaction of an alcohol having 3 to 22 carbon atoms with 2-pentenenitrile to form a branched alkyl ether nitrile. The etheraminonitriles formed by the process are hydrogenated to form alkylether amines. The resulting product can be reacted with 2-pentenenitrile and or acrylonitrile and in subsequent step, hydrogenated to yield a diamine. Specifically, the present invention deals with two types of tertiary amines one made by the reaction of novel ether diamines compounds with ethylene oxide, propylene oxide or butylene oxide or mixtures thereof, producing alkoxylated tertiary amines and the other made by the reaction of novel ether amine compounds with formaldehyde and hydrogen producing methylated tertiary amines. The invention also disclosed novel amine oxides, and quaternary compounds made from said tertiary amines.Type: GrantFiled: January 22, 2002Date of Patent: July 30, 2002Assignee: Nova Molecular Technologies Inc.Inventors: Thomas J. Daly, Michael Clumpner, Anthony J. O'Lenick, Jr.
-
Patent number: 6417401Abstract: The present invention is related to a series of derivatives of novel ether diamine compounds prepared by the cyanobutylation reaction of an alcohol having 3 to 22 carbon atoms with 2-pentenenitrile to form a branched alkyl ether nitrile. The etheraminonitriles formed by the process are hydrogenated to form alkylether amines. The resulting product can be reacted with 2-pentenenitrile and or acrylonitrile and in a subsequent step, hydrogenated to yield a diamine. Specifically, the present invention deals with two types of tertiary amines one made by the reaction of novel ether diamines compounds with ethylene oxide, propylene oxide or butylene oxide or mixtures thereof, producing alkoxylated tertiary amines and the other made by the reaction of novel ether amine compounds with formaldehyde and hydrogen producing methylated tertiary amines. The invention also disclosed novel amine oxides, and quaternary compounds made from said tertiary amines.Type: GrantFiled: January 22, 2002Date of Patent: July 9, 2002Assignee: Nova Molecular Technologies INCInventors: Thomas J. Daly, Michael Clumpner, Anthony J. O'Lenick, Jr.
-
Patent number: 6331648Abstract: The present invention relates to a series of derivatives of novel ether amine compounds prepared by the cyanobutylation reaction of an alcohol having 3 to 22 carbon atoms with 2-pentenenitrile to form a branched alkyl ether nitrile. The alkyl ether nitrites formed by the process are hydrogenated to form alkylether amines. The resulting product can be reacted with 2-pentenenitrile and or acrylonitrile and in a subsequent step, hydrogenated to yield a diamine. Specifically, the present invention deals with two types of tertiary amines one made by the reaction of novel ether amine compounds with ethylene oxide, propylene oxide or butylene oxide or mixtures thereof producing alkoxylated tertiary amines and the other made by the reaction of novel ether amine compounds with formaldehyde and hydrogen producing methylated tertiary amines. The invention also discloses novel amine oxides, and quaternary compounds made from said tertiary amines.Type: GrantFiled: May 8, 2000Date of Patent: December 18, 2001Assignee: Nova Molecular Technologies INCInventors: Thomas J. Daly, Michael Clumpner, Anthony J. O'Lenick, Jr.
-
Patent number: 6114585Abstract: The present invention relates to a series of novel ether amine compounds prepared by the cyanobutylation reaction of an alcohol having 12 to 26 carbon atoms with 2-pentenenitrile to form a branched alkyl ether nitrile. The etheraminonitriles formed by the process are hydrogenated to form alkylether amines. The resulting product can be reacted with 2-pentenenitrile and hydrogenated to yield a polyamine.Type: GrantFiled: December 13, 1999Date of Patent: September 5, 2000Assignee: Nova Molecular Technologies IncInventors: Thomas J. Daly, Anita Mokadam Sorhaug, Robert E. Harbour, Jr., Abraham A. Zahand, Michael Clumpner, Anthony J. O'Lenick, Jr.
-
Patent number: 5792619Abstract: An oxidative chromogenic reagent free from interference by bilirubin used for the measurement of a biogenic substance by an enzymatic analysis, which comprises a compound or a salt thereof represented by the following formula wherein R.sup.1 and R.sup.2 independently represent a C.sub.3-4 -alkly group substituted with a sulfonic acid group or a C.sub.3-4 -hydroxyalkyl group substituted with a sulfonic acid group; and R.sup.3 and R.sup.4 independently represent a C.sub.1-4 -alkyl group, a C.sub.1-4 -alkoxy group, a substituted or non-substituted carbamoyl group, an acyl-substituted amino group, an aryl group, or a halogen atom. The reagent is stable and has excellent water solubility, and it enables high sensitive and accurate measurement because interference by bilirubin is substantially reduced or eliminated.Type: GrantFiled: January 30, 1997Date of Patent: August 11, 1998Assignee: Dojindo Molecular Technologies, Inc.Inventor: Makoto Mizoguchi